Although independent studies have confirmed that TH588 inhibits MTH1 at nanomolar concentrations4–8, accumulating evidence suggests that its anti-cancer effect is mediated by other mechanisms: First, the concentrations of TH588 required for its cytotoxic effect are several fold higher than those required for MTH1 inhibition1,5. The gene discussed is NUDT1; the disease is cancer.